Abstract Objective To study the correlations of IL-4R gene polymorphism and serum IgE levels with asthma predictive index (API) in children. Methods One hundred and sixty-seven children with positive API, 187 children with negative API and 203 healthy children (control group) were enrolled. PCR and DNA sequencing were used to identify genotypes of the Arg551Gln locus in IL-4R gene. Serum IgE levels were measured using ELISA. Results There was no significant difference in the genotype frequencies of the Arg551Gln locus in IL-4R gene among the positive API, negative API and control groups. Serum IgE levels in the positive API group were significantly higher than in the negative API and control groups (PPConclusions There is no correlation between the Arg551Gln polymorphism in IL-4R gene and API results. API positivity is correlated with elevated serum IgE levels. An older age (>2 years) may be a risk factor for increased serum IgE levels in children with positive API.
Stavric K, Peova S, Trajkov D, et al. Gene polymorphisms of 22 cytokines in Macedonian children with atopic dermatitis[J]. Iran J Allergy Asthma Immunol, 2012, 11(1):37-50.
[3]
Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children[J]. N Engl J Med, 2011, 364(11):1005-1015.
Lötvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome[J]. J Allergy Clin Immunol, 2011, 127(2): 355-360.
Tanaka K, Sugiura H, Uehara M, et al. Lack of association between atopic eczema and the genetic variants of interleukin-4 and the interleukin-4 receptor α chain gene:heterogeneity of genetic backgrounds on immunoglobulin E production in atopic eczema patients[J]. Clin Exp Allergy, 2001, 31(10):1522-1527.
[8]
Lee SG, Kim BS, Kim JH, et al. Gene-gene interaction between interleukin-4 and interleukin-4 receptor α in Korean children with asthma[J]. Clin Exp Allergy, 2004, 34(8):1202-1208.
[9]
Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma[J]. J Allergy Clin Immunol, 2001, 108(2):184-190.
[10]
Patelis A, Janson C, Borres MP, et al. Aeroallergen and food IgE sensitization and local and systemic inflammation in asthma[J]. Allergy, 2014, 69(3):380-387.
[11]
Sunyer J, Pekkanen J, Garcia-Esteban R, et al. Asthma score: predictive ability and risk factors[J]. Allergy, 2007, 62(2):142-148.
Kim JH, Cheong HS, Park JS, et al. A genome-wide association study of total serum and mite-specific IgEs in asthma patients[J]. PLoS One, 2013, 8(8):e71958.
